Dr. Ionela Iacobas, assistant professor of pediatrics at Baylor and Texas Children’s Cancer Center, served as co-chair of the second International Conference on Generalized Lymphatic Anomaly and Gorham-Stout Disease, held last month in Atlanta.

The conference brought together more than 60 physicians and scientists from around the world to present new advances in the field and establish a consensus for evaluation and monitoring guidelines of these complex lymphatic abnormalities.

In addition to Iacobas, who co-chaired, along with Dr. Michael Dellinger of the Lymphatic Malformation Institute, five other specialists from Baylor and Texas Children’s Hospital participated, including:

As an international leader in pediatric cancer research and treatment, Texas Children’s Cancer and Hematology Centers are joint programs of Texas Children's Hospital and Baylor College of Medicine. The Centers are dedicated to providing novel therapies and family-centered care to children from infancy through young adulthood with cancer and blood disorders – from the most common to very rare. Texas Children’s Cancer Center is the pediatric program of BCM’s NCI-designated Dan L. Duncan Cancer Center.
Ranked by U.S. News & World Report as the #2 Center in the United States, Texas Children’s Cancer and Hematology Centers treats more childhood cancer and hematology patients than any other program in the U.S., with patients coming from 35 states and 26 countries around the world.